Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems

References

• Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Vaccine 2012; 31:96-108; PMID:23142307; http://dx.doi.org/10.1016/j.vaccine.2012.10.103
   PubMed Web of Science ®Google Scholar
• Levine MM. “IDEAL” vaccines for resource poor settings. Vaccine 2011; 29 Suppl 4:D116-25; PMID:22486974; http://dx.doi.org/10.1016/j.vaccine.2011.11.090
   PubMedGoogle Scholar
• Chen D, Zehrung D. Desirable attributes of vaccines for deployment in low-resource settings. J Pharm Sci 2012; 102:29-33; PMID:23136115; http://dx.doi.org/10.1002/jps.23352
   PubMed Web of Science ®Google Scholar
• Childress BC, Montney JD, Albro EA. Making evidence-based selections of influenza vaccines. Hum Vaccin Immunother 2014; 10:2729-32; PMID:25483499; http://dx.doi.org/10.4161/hv.29340
   PubMed Web of Science ®Google Scholar
• Domingues CM, de Fatima Pereira S, Cunha Marreiros AC, Menezes N, Flannery B. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program. J Infect Dis 2014; 210 Suppl 1:S143-51; PMID:25316829; http://dx.doi.org/10.1093/infdis/jit588
   PubMed Web of Science ®Google Scholar
• Low N, Bavdekar A, Jeyaseelan L, Hirve S, Ramanathan K, Andrews NJ, Shaikh N, Jadi RS, Rajagopal A, Brown KE, et al. A randomized, controlled trial of an aerosolized vaccine against measles. N Engl J Med 2015; 372:1519-29; PMID:25875257; http://dx.doi.org/10.1056/NEJMoa1407417
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012; 64:1547-68; PMID:22575858; http://dx.doi.org/10.1016/j.addr.2012.04.005
   PubMed Web of Science ®Google Scholar
• Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. Journal of pharmaceutical sciences 1998; 87:922-5; PMID:9687334; http://dx.doi.org/10.1021/js980042+
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-based vaccines. Curr Top Microbiol Immunol 2009; 333:369-93; PMID:19768415.
   PubMedGoogle Scholar
• Pattani A, McKay PF, Garland MJ, Curran RM, Migalska K, Cassidy CM, Malcolm RK, Shattock RJ, McCarthy HO, Donnelly RF. Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. J Control Release 2012; 162:529-37; PMID:22960496; http://dx.doi.org/10.1016/j.jconrel.2012.07.039
   PubMed Web of Science ®Google Scholar
• Norman JJ, Arya JM, McClain MA, Frew PM, Meltzer MI, Prausnitz MR. Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine 2014; 32:1856-62; PMID:24530146; http://dx.doi.org/10.1016/j.vaccine.2014.01.076
   PubMed Web of Science ®Google Scholar
• Pearton M, Kang SM, Song JM, Kim YC, Quan FS, Anstey A, Ivory M, Prausnitz MR, Compans RW, Birchall JC. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 2010; 28:6104-13; PMID:20685601; http://dx.doi.org/10.1016/j.vaccine.2010.05.055
   PubMed Web of Science ®Google Scholar
• Zipursky S, Djingarey MH, Lodjo JC, Olodo L, Tiendrebeogo S, Ronveaux O. Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin. Vaccine 2014; 32:1431-5; PMID:24559895; http://dx.doi.org/10.1016/j.vaccine.2014.01.038
   PubMed Web of Science ®Google Scholar
• Al-Zahrani S, Zaric M, McCrudden C, Scott C, Kissenpfennig A, Donnelly RF. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv 2012; 9:541-50; PMID:22475249; http://dx.doi.org/10.1517/17425247.2012.676038
   PubMed Web of Science ®Google Scholar
• van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 2012; 161:645-55; PMID:22342643; http://dx.doi.org/10.1016/j.jconrel.2012.01.042
   PubMed Web of Science ®Google Scholar
• Wang T, Zhen YY, Ma XY, Wei BA, Li SQ, Wang NN. Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain. Colloid Surface B 2015; 126:520-30; http://dx.doi.org/10.1016/j.colsurfb.2015.01.005
   PubMed Web of Science ®Google Scholar
• DeMuth PC, Min Y, Huang B, Kramer JA, Miller AD, Barouch DH, Hammond PT, Irvine DJ. Polymer multilayer tattooing for enhanced DNA vaccination. Nature materials 2013; 12:367-76; PMID:23353628; http://dx.doi.org/10.1038/nmat3550
   PubMed Web of Science ®Google Scholar
• Wang T, Wang N. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant-Delivery System for Cutaneous and Mucosal Vaccination. Curr Pharm Design 2015; 21:5245-55; http://dx.doi.org/10.2174/1381612821666150923100147
   PubMed Web of Science ®Google Scholar
• Haq MI, Smith E, John DN, Kalavala M, Edwards C, Anstey A, Morrissey A, Birchall JC. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 2009; 11:35-47; PMID:18663579; http://dx.doi.org/10.1007/s10544-008-9208-1
   PubMed Web of Science ®Google Scholar
• Levin Y, Kochba E, Kenney R. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same? Vaccine 2014; 32:4249-52; PMID:24930715; http://dx.doi.org/10.1016/j.vaccine.2014.03.024
   PubMed Web of Science ®Google Scholar
• Hirobe S, Azukizawa H, Hanafusa T, Matsuo K, Quan YS, Kamiyama F, Katayama I, Okada N, Nakagawa S. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials 2015; 57:50-8; PMID:25913250; http://dx.doi.org/10.1016/j.biomaterials.2015.04.007
   PubMed Web of Science ®Google Scholar
• Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008; 35:193-202; PMID:18657610; http://dx.doi.org/10.1016/j.ejps.2008.06.016
   PubMed Web of Science ®Google Scholar
• Anand A, Zaman K, Estivariz CF, Yunus M, Gary HE, Weldon WC, Bari TI, Steven Oberste M, Wassilak SG, Luby SP, et al. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. Vaccine 2015; 33:6816-22; PMID:26476367; http://dx.doi.org/10.1016/j.vaccine.2015.09.039
   PubMed Web of Science ®Google Scholar
• Wendorf JR, Ghartey-Tagoe EB, Williams SC, Enioutina E, Singh P, Cleary GW. Transdermal Delivery of Macromolecules Using Solid-State Biodegradable Microstructures. Pharm Res-Dordr 2011; 28:22-30; http://dx.doi.org/10.1007/s11095-010-0174-y
   PubMed Web of Science ®Google Scholar
• Yang S, Feng Y, Zhang L, Chen N, Yuan W, Jin T. A scalable fabrication process of polymer microneedles. International journal of nanomedicine 2012; 7:1415-22; PMID:22457598.
   PubMed Web of Science ®Google Scholar
• Bystrova S, Luttge R. Micromolding for ceramic microneedle arrays. Microelectron Eng 2011; 88:1681-4; http://dx.doi.org/10.1016/j.mee.2010.12.067
   Web of Science ®Google Scholar
• Wilke N, Mulcahy A, Ye SR, Morrissey A. Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectron J 2005; 36:650-6; http://dx.doi.org/10.1016/j.mejo.2005.04.044
   Web of Science ®Google Scholar
• Donnelly RF, Majithiya R, Singh TRR, Morrow DIJ, Garland MJ, Demir YK, Migalska K, Ryan E, Gillen D, Scott CJ, et al. Design, Optimization and Characterisation of Polymeric Microneedle Arrays Prepared by a Novel Laser-Based Micromoulding Technique. Pharmaceutical research 2011; 28:41-57.
   PubMed Web of Science ®Google Scholar
• Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery. Journal of Controlled Release 2005; 104:51-66; PMID:15866334; http://dx.doi.org/10.1016/j.jconrel.2005.02.002
   PubMed Web of Science ®Google Scholar
• Qin D, Xia YN, Whitesides GM. Soft lithography for micro- and nanoscale patterning. Nat Protoc 2010; 5:491-502; PMID:20203666; http://dx.doi.org/10.1038/nprot.2009.234
   PubMed Web of Science ®Google Scholar
• Watanabe T, Hagino K, Sato T. Evaluation of the effect of polymeric microneedle arrays of varying geometries in combination with a high-velocity applicator on skin permeability and irritation. Biomed Microdevices 2014; 16:591-7; PMID:24733417; http://dx.doi.org/10.1007/s10544-014-9861-5
   PubMed Web of Science ®Google Scholar
• Bal SM, Kruithof AC, Zwier R, Dietz E, Bouwstra JA, Lademann J, Meinke MC. Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo. Journal of Controlled Release 2010; 147:218-24; PMID:20650292; http://dx.doi.org/10.1016/j.jconrel.2010.07.104
   PubMed Web of Science ®Google Scholar
• Ai-Qallaf B, Das DB. Optimization of square microneedle arrays for increasing drug permeability in skin. Chem Eng Sci 2008; 63:2523-35; http://dx.doi.org/10.1016/j.ces.2008.02.007
   Web of Science ®Google Scholar
• Edens C, Collins ML, Goodson JL, Rota PA, Prausnitz MR. A microneedle patch containing measles vaccine is immunogenic in non-human primates. Vaccine 2015; 33:4712-4718. http://dx.doi.org/10.1016/j.vaccine.2015.02.074.
   Web of Science ®Google Scholar
• Wang T, Zhen Y, Ma X, Wei B, Li S, Wang N. Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain. Colloids Surf B Biointerfaces 2015; 126:520-30; PMID:25612819; http://dx.doi.org/10.1016/j.colsurfb.2015.01.005
   PubMed Web of Science ®Google Scholar
• Zhang J, Pritchard E, Hu X, Valentin T, Panilaitis B, Omenetto FG, Kaplan DL. Stabilization of vaccines and antibiotics in silk and eliminating the cold chain. Proceedings of the National Academy of Sciences of the United States of America 2012; 109:11981-6; PMID:22778443; http://dx.doi.org/10.1073/pnas.1206210109
   PubMed Web of Science ®Google Scholar
• Wang T, Zhen Y, Ma X, Wei B, Wang N. Phospholipid bilayer-coated aluminum nanoparticles as an effective vaccine adjuvant-delivery system. ACS applied materials & interfaces 2015; 7:6391-6; PMID:25780860; http://dx.doi.org/10.1021/acsami.5b00348
   PubMed Web of Science ®Google Scholar
• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of molecular biology 1965; 13:238-52; PMID:5859039; http://dx.doi.org/10.1016/S0022-2836(65)80093-6
   PubMed Web of Science ®Google Scholar
• Wang T, Wang N, Sun W, Li T. Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions. Chem Phys Lipids 2011; 164:151-7; PMID:21185814; http://dx.doi.org/10.1016/j.chemphyslip.2010.12.005
   PubMed Web of Science ®Google Scholar
• Wang T, Deng Y, Geng Y, Gao Z, Zou J, Wang Z. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. Biochim Biophys Acta 2006; 1758:222-31; PMID:16563340; http://dx.doi.org/10.1016/j.bbamem.2006.01.023
   PubMed Web of Science ®Google Scholar
• Wang T, Wang N, Jin X, Zhang K, Li T. A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions. J Liposome Res 2009; 19:231-40; PMID:19263267; http://dx.doi.org/10.1080/08982100902788390
   PubMed Web of Science ®Google Scholar
• Alving CR, Rao M, Steers NJ, Matyas GR, Mayorov AV. Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines. Expert Rev Vaccines 2012; 11:733-44; PMID:22873129; http://dx.doi.org/10.1586/erv.12.35
   PubMed Web of Science ®Google Scholar
• Shariat S, Badiee A, Jaafari MR, Mortazavi SA. Optimization of a Method to Prepare Liposomes Containing HER2/Neu-Derived Peptide as a Vaccine Delivery System for Breast Cancer. Iran J Pharm Res 2014; 13:15-25; PMID:24711825.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang T, Zhang ML, Chen RN, Niu RW, Deng YH. Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system. Eur J Pharm Biopharm 2014; 88:194-206; PMID:24769065; http://dx.doi.org/10.1016/j.ejpb.2014.04.007
   PubMed Web of Science ®Google Scholar
• Guo L, Chen J, Qiu Y, Zhang S, Xu B, Gao Y. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. Int J Pharm 2013; 447:22-30; PMID:23410987; http://dx.doi.org/10.1016/j.ijpharm.2013.02.006
   PubMed Web of Science ®Google Scholar
• Qiu Y, Guo L, Zhang S, Xu B, Gao Y, Hu Y, Hou J, Bai B, Shen H, Mao P. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN. Drug delivery 2016 (in press); http://dx.doi.org/10.3109/10717544.2014.992497
   Google Scholar
• Slutter B, Bal SM, Ding Z, Jiskoot W, Bouwstra JA. Adjuvant effect of cationic liposomes and CpG depends on administration route. J Control Release 2011; 154:123-30; PMID:21315779; http://dx.doi.org/10.1016/j.jconrel.2011.02.007
   PubMed Web of Science ®Google Scholar
• Moon JJ, Suh H, Bershteyn A, Stephan MT, Liu H, Huang B, Sohail M, Luo S, Um SH, Khant H, et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nature materials 2011; 10:243-51; PMID:21336265; http://dx.doi.org/10.1038/nmat2960
   PubMed Web of Science ®Google Scholar
• DeMuth PC, Moon JJ, Suh H, Hammond PT, Irvine DJ. Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery. ACS Nano 2012; 6:8041-51; PMID:22920601; http://dx.doi.org/10.1021/nn302639r
   PubMed Web of Science ®Google Scholar
• Zhen YY, Wang N, Gao ZB, Ma XY, Wei BA, Deng YH, Wang T. Multifunctional liposomes constituting microneedles induced robust systemic and mucosal immunoresponses against the loaded antigens via oral mucosal vaccination. Vaccine 2015; 33:4330-40; PMID:25858854; http://dx.doi.org/10.1016/j.vaccine.2015.03.081
   PubMed Web of Science ®Google Scholar
• Wang T, Wang N, Song H, Xi X, Wang J, Hao A, Li T. Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine. Eur J Pharm Sci 2011; 44:127-35; PMID:21742030; http://dx.doi.org/10.1016/j.ejps.2011.06.015
   PubMed Web of Science ®Google Scholar
• Wang N, Wang T, Zhang M, Chen R, Deng Y. Using procedure of emulsification-lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS). Int J Pharm 2014; 468:39-49; PMID:24704308; http://dx.doi.org/10.1016/j.ijpharm.2014.04.002
   PubMed Web of Science ®Google Scholar
• Desai SN, Kamat D. Closing the global immunization gap: delivery of lifesaving vaccines through innovation and technology. Pediatrics in review / American Academy of Pediatrics 2014; 35:e32-40; PMID:24986933; http://dx.doi.org/10.1542/pir.35-7-e32
   PubMedGoogle Scholar
• DeMuth PC, Li AV, Abbink P, Liu J, Li H, Stanley KA, Smith KM, Lavine CL, Seaman MS, Kramer JA, et al. Vaccine delivery with microneedle skin patches in nonhuman primates. Nature biotechnology 2013; 31:1082-5; PMID:24316643; http://dx.doi.org/10.1038/nbt.2759
   PubMed Web of Science ®Google Scholar
• Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007; 316:1628-32; PMID:17569868; http://dx.doi.org/10.1126/science.1138963
   PubMed Web of Science ®Google Scholar
• Casella CR, Mitchell TC. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol Life Sci 2008; 65:3231-40; PMID:18668203; http://dx.doi.org/10.1007/s00018-008-8228-6
   PubMed Web of Science ®Google Scholar
• Ohimain EI. Recent advances in the development of vaccines for Ebola virus disease. Virus Res 2016; 211:174-85; PMID:26596227; http://dx.doi.org/10.1016/j.virusres.2015.10.021
   PubMed Web of Science ®Google Scholar
• Allison SD. Effect of structural relaxation on the preparation and drug release behavior of poly(lactic-co-glycolic)acid microparticle drug delivery systems. Journal of pharmaceutical sciences 2008; 97:2022-35; PMID:17828755; http://dx.doi.org/10.1002/jps.21124
   PubMed Web of Science ®Google Scholar
• Ungaro F, d'Angelo I, Miro A, La Rotonda MI, Quaglia F. Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises. The Journal of pharmacy and pharmacology 2012; 64:1217-35; PMID:22881435; http://dx.doi.org/10.1111/j.2042-7158.2012.01486.x
   PubMed Web of Science ®Google Scholar
• Joshi VB, Geary SM, Salem AK. Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses. Human vaccines & immunotherapeutics 2013; 9:2584-90; PMID:23978910; http://dx.doi.org/10.4161/hv.26136
   PubMed Web of Science ®Google Scholar
• Silva AL, Rosalia RA, Varypataki E, Sibuea S, Ossendorp F, Jiskoot W. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation. Vaccine 2015; 33:847-54; PMID:25576216; http://dx.doi.org/10.1016/j.vaccine.2014.12.059
   PubMed Web of Science ®Google Scholar
• Zaric M, Lyubomska O, Touzelet O, Poux C, Al-Zahrani S, Fay F, Wallace L, Terhorst D, Malissen B, Henri S, et al. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS nano 2013; 7:2042-55; PMID:23373658; http://dx.doi.org/10.1021/nn304235j
   PubMed Web of Science ®Google Scholar
• Zaric M, Lyubomska O, Poux C, Hanna ML, McCrudden MT, Malissen B, Ingram RJ, Power UF, Scott CJ, Donnelly RF, et al. Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells. J Invest Dermatol 2015; 135:425-34; PMID:25243789; http://dx.doi.org/10.1038/jid.2014.415
   PubMed Web of Science ®Google Scholar
• Demuth PC, Garcia-Beltran WF, Ai-Ling ML, Hammond PT, Irvine DJ. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination. Advanced functional materials 2013; 23:161-72; PMID:23503923; http://dx.doi.org/10.1002/adfm.201201512
   PubMed Web of Science ®Google Scholar
• Smith A, Perelman M, Hinchcliffe M. Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines. Human vaccines & immunotherapeutics 2014; 10:797-807; PMID:24346613; http://dx.doi.org/10.4161/hv.27449
   PubMed Web of Science ®Google Scholar
• Bal SM, Ding Z, Kersten GF, Jiskoot W, Bouwstra JA. Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations. Pharm Res 2010; 27:1837-47; PMID:20559701; http://dx.doi.org/10.1007/s11095-010-0182-y
   PubMed Web of Science ®Google Scholar
• Bal SM, Slutter B, Jiskoot W, Bouwstra JA. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation. Vaccine 2011; 29:4025-32; PMID:21443959; http://dx.doi.org/10.1016/j.vaccine.2011.03.039
   PubMed Web of Science ®Google Scholar
• Leguen E, Chassepot A, Decher G, Schaaf P, Voegel JC, Jessel N. Bioactive coatings based on polyelectrolyte multilayer architectures functionalized by embedded proteins, peptides or drugs. Biomolecular engineering 2007; 24:33-41; PMID:16860599; http://dx.doi.org/10.1016/j.bioeng.2006.05.023
   PubMedGoogle Scholar
• Kim BS, Park SW, Hammond PT. Hydrogen-bonding layer-by-layer assembled biodegradable polymeric micelles as drug delivery vehicles from surfaces. Acs Nano 2008; 2:386-92; PMID:19206641; http://dx.doi.org/10.1021/nn700408z
   PubMed Web of Science ®Google Scholar
• Zeltins A. Construction and characterization of virus-like particles: a review. Mol Biotechnol 2013; 53:92-107; PMID:23001867; http://dx.doi.org/10.1007/s12033-012-9598-4
   PubMed Web of Science ®Google Scholar
• Rodriguez-Limas WA, Sekar K, Tyo KEJ. Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development. Curr Opin Biotech 2013; 24:1089-93; PMID:23481378; http://dx.doi.org/10.1016/j.copbio.2013.02.008
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Vekemans J, Richie TL, Duffy PE. The march toward malaria vaccines. Vaccine 2015; 33 Suppl 4:D13-23; PMID:26324116; http://dx.doi.org/10.1016/j.vaccine.2015.07.091
   PubMedGoogle Scholar
• Quan FS, Kim YC, Vunnava A, Yoo DG, Song JM, Prausnitz MR, Compans RW, Kang SM. Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization. Journal of virology 2010; 84:7760-9; PMID:20484519; http://dx.doi.org/10.1128/JVI.01849-09
   PubMed Web of Science ®Google Scholar
• Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, Yoo DG, Park KM, Chen LM, Quan FS, Birchall JC, et al. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol 2010; 17:1381-9; PMID:20631330; http://dx.doi.org/10.1128/CVI.00100-10
   PubMed Web of Science ®Google Scholar
• Song JM, Kim YC, Barlow PG, Hossain MJ, Park KM, Donis RO, Prausnitz MR, Compans RW, Kang SM. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antivir Res 2010; 88:244-7; PMID:20851715; http://dx.doi.org/10.1016/j.antiviral.2010.09.001
   PubMed Web of Science ®Google Scholar
• Pearton M, Pirri D, Kang SM, Compans RW, Birchall JC. Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine. Advanced healthcare materials 2013; 2:1401-10; PMID:23564440; http://dx.doi.org/10.1002/adhm.201300006
   PubMed Web of Science ®Google Scholar
• Kim MC, Lee JW, Choi HJ, Lee YN, Hwang HS, Lee J, Kim C, Lee JS, Montemagno C, Prausnitz MR, et al. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection. J Control Release 2015; 210:208-16; PMID:26003039; http://dx.doi.org/10.1016/j.jconrel.2015.05.278
   PubMed Web of Science ®Google Scholar
• Kines RC, Zarnitsyn V, Johnson TR, Pang YYS, Corbett KS, Nicewonger JD, Gangopadhyay A, Chen M, Liu J, Prausnitz MR, et al. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles. PLos One 2015; 10: e0120797-0120814. PMID:25785935; http://dx.doi.org/10.1371/10.1371/journal.pone.0120797
   PubMed Web of Science ®Google Scholar
• Carey JB, Pearson FE, Vrdoljak A, McGrath MG, Crean AM, Walsh PT, Doody T, O'Mahony C, Hill AV, Moore AC. Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice. PLoS One 2013; 6:e22442.
   Web of Science ®Google Scholar
• Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 2006; 6:148-58; PMID:16491139; http://dx.doi.org/10.1038/nri1777
   PubMed Web of Science ®Google Scholar
• Lutton RE, Moore J, Larraneta E, Ligett S, Woolfson AD, Donnelly RF. Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res 2015; 5:313-31; PMID:26022578; http://dx.doi.org/10.1007/s13346-015-0237-z
   PubMed Web of Science ®Google Scholar
• Suh H, Shin J, Kim YC. Microneedle patches for vaccine delivery. Clin Exp Vaccine Res 2014; 3:42-9; PMID:24427762; http://dx.doi.org/10.7774/cevr.2014.3.1.42
   PubMedGoogle Scholar
• Kolli CS. Microneedles: bench to bedside. Ther Deliv 2015; 6:1081-8; PMID:26419290; http://dx.doi.org/10.4155/tde.15.67
   PubMedGoogle Scholar
• Jacoby E, Jarrahian C, Hull HF, Zehrung D. Opportunities and challenges in delivering influenza vaccine by microneedle patch. Vaccine 2015; 33:4699-704; PMID:25842218; http://dx.doi.org/10.1016/j.vaccine.2015.03.062
   PubMed Web of Science ®Google Scholar
• Arya J, Prausnitz MR. Microneedle patches for vaccination in developing countries. J Control Release 2016 (in press); PMID:26603347; http://dx.doi.org/10.1016/j.jconrel.2015.11.019
   Google Scholar
• Korschun H. Clinical study at Emory tests microneedle skin patches as alternative to flu shot. Researchers are enrolling volunteers in a clinical study at the Hope Clinic of the Emory Vaccine Center. Emory University: Emory University Woodruff Health Sciences Center, August 28, 2015.
   Google Scholar
• Toon J. Polio vaccination with microneedle patches receives funding for patch development, clinical trial. Clinical Trial Will Evaluate Polio Vaccination Using Microneedle Patch. Georgia Institute of Technology, Atlanta, Georgia 30332-0181 USA: Georgia Institute of Technology News Center, February 24, 2015.
   Google Scholar
• Meek G. Microneedle Patch for Measles Vaccination Could Be a Game Changer. Promises to Increase Reach of Immunization Coverage Globally: CDC Newsroom Releases, April 27, 2015.
   Google Scholar